Activity

Personas, frequently utilized in recent pain research initiatives, and recognized for their pivotal role in the design process, nevertheless lack transparently communicated and consistently applied design guidelines for their creation and utilization. To inform future eHealth endeavors and improve the quality of eHealth innovation in pain management, this exploration examines both the benefits and challenges of utilizing personas in the development of eHealth interventions for individuals with chronic pain.

The emotional toll of a lung cancer diagnosis is substantial, compounded by the common occurrence of late-stage diagnoses, which drastically reduce anticipated life expectancy. While effective educational, emotional, and social interventions exist, their reach is unfortunately limited, and assistance is frequently delayed until a point when such interventions are less impactful.

In a comprehensive center for cancer care and health research, this project will investigate the efficiency, economic implications, and usefulness of an eHealth infrastructure to address the psychosocial requirements of patients with advanced lung cancer.

Within a nine-month period, seventy-six individuals with advanced lung cancer will participate in a personalized, phased psychosocial care program facilitated through an eHealth ecosystem. Within the framework of a non-inferiority randomized controlled trial, these patients will be compared with 76 others receiving routine care. At three-month intervals, the following key outcomes will be evaluated: emotional distress, spirituality, demoralization, quality of life, and medication adherence. Symptomatology, health education, cost-utility analyses, platform usability and satisfaction, and the time to recognize and address emotional needs will be among the secondary outcomes. Employing the Student’s t-test, baseline distinctions between the groups will be evaluated.

In accordance with the data, choose between a chi-square test and a suitable alternative test. Using multilevel linear models, we will then analyze the principal outcomes over time within each group, reporting effect sizes (Hedges’ g).

Rephrase the sentence on the topic of assessing non-inferiority, producing ten unique sentence structures. Evaluating the cost-benefit of both treatments involves examining quality-adjusted life years, perceived quality of life, and the expenses of delivering each intervention.

This randomized controlled trial of an eHealth system aims to generate new data on the efficacy and cost-effectiveness of providing personalized and timely psychosocial care tailored for patients facing advanced lung cancer.

ClinicalTrials.gov is a repository of details regarding clinical trials. Further research on the clinical trial with identifier NCT05497973 is imperative.

ClinicalTrials.gov is a valuable resource for researchers and patients seeking information about clinical trials. A thorough examination of the clinical trial, NCT05497973, is paramount.

Assertiveness training has proven to be an indispensable element in cognitive-behavioral therapy (CBT), proving beneficial in the treatment of social anxiety, and a similar practice is seen in dialectical behavioral therapy. In contrast, the construct of assertiveness has not been extensively examined in current clinical research. The purpose of this research was to explore the efficacy of an internet-based, transdiagnostic CBT intervention, lasting eight weeks, geared towards boosting assertive behaviors. Following the inclusion criteria, we randomly assigned 210 participants to three groups: therapist-guided self-help, unguided self-help, and a waitlist control group. crm1 receptor At the one-year mark, we utilized a linear mixed model approach to measure the consequences of primary outcome measures, such as assertiveness (using the Adaptive and Aggressive Assertiveness Scales, along with the Rathus Assertiveness Schedule), and secondary outcome measures including anxiety, depression, and general well-being, at the post-test and follow-up phases. Reliable clinical changes were also a subject of our assessment. Regarding self-rated adaptive assertiveness, there was a statistically identical effect size between the two treatment groups and the post-treatment wait list, at both the post-treatment and the one-year follow-up. The effect sizes ranged from 0.95 to 1.73, yielding reliable clinical recovery proportions between 19% and 36%. Following the intervention, there was a noticeable rise in aggressive assertiveness, with an effect size (ES) ranging from 0.62 to 0.90, when compared to the wait-list group at the post-intervention stage. Compared to the waitlist, post-treatment interventions for social anxiety symptoms produced effect sizes between 0.67 and 0.93, directly linked to a dependable clinical recovery rate of 16% to 26%. Post-intervention, the self-assessed well-being effects, when compared to the waitlist condition, demonstrated a range of effect sizes (ES) from 0.70 to 1.05. Generalized anxiety displayed no measurable effect, although a medium-sized effect was found in depression one year following treatment when examining each group individually. From a broad perspective, the two treatment approaches resulted in similar outcomes. Generally, participation fostered healthier, more assertive expressions, irrespective of the treatment group, concurrently decreasing self-reported social anxiety and, with the passage of time, potentially alleviating depressive symptoms. General well-being benefited from the act of participation. The assertiveness construct, as evidenced by the findings, is a viable intervention target, leading to a decrease in psychiatric symptoms and daily life non-syndromal issues. The ClinicalTrials.gov database pre-registered the study. The JSON schema related to NCT04240249 must be returned to ensure proper data processing.

A high prevalence of postpartum depression is observed in Chile, along with a concerning treatment gap. Obstacles to postpartum depression care highlight the necessity of more readily available and affordable interventions. The extensive use of digital tools in every social group within Chile, along with the growing prevalence of pregnancy and parenting apps, offers potential for mobile-based intervention programs. In high-income countries, internet-based cognitive-behavioral interventions have demonstrated effectiveness in reducing depressive symptom presentation. Nevertheless, the field of remains underdeveloped in Chile. This randomized controlled trial protocol, documented in this manuscript, is designed to assess the efficacy and acceptance of a guided, 8-week, cognitive-behavioral mobile app intervention intended for Chilean postpartum women with depressive symptoms.

A two-armed, parallel study, on a limited scale, is scheduled. Postpartum women experiencing depressive symptoms, varying in severity from minor to major, will be randomly allocated to either an app-based intervention or a waitlist control. Intervention and study adherence, coupled with recruitment and eligibility rates, and participants’ satisfaction, engagement, and utilization of the intervention, define the primary outcomes in terms of feasibility and acceptability. The intervention’s effect on the participants’ experiences can be further examined through semi-structured interviews conducted with a subset of participants. Women’s depression status will be evaluated before, after, and one month following treatment. In addition to other primary measures, participants’ perceptions of social support, mother-infant bonding, and maternal satisfaction and self-efficacy will be evaluated as secondary outcomes.

This internet-based intervention is the first of its kind to be developed and researched in Chile with the aim of reducing postpartum depression symptoms. Considering the feasibility and acceptability of the intervention and procedures, we propose to investigate its effectiveness in a controlled trial of definitive scope. If the intervention proves effective, the intent is to integrate it into Chile’s healthcare infrastructure.

The first internet-based intervention, focused on diminishing postpartum depression symptoms, is being researched and developed in Chile. If the intervention and procedures demonstrate both practicality and acceptability, a subsequent controlled trial will be undertaken to investigate its efficacy. Should the intervention prove effective, its implementation within the Chilean healthcare system is anticipated.

A wealth of scholarly work highlights the fact that psychological distress not only severely endangers mental health but also significantly impacts physical well-being. This can negatively affect the prognosis and recovery period after treatment in individuals with cancer. Researchers have recently directed their attention toward the efficacy of digital health adaptations of established psychological approaches, recognizing the frequent inaccessibility of face-to-face interventions for cancer patients. In this context, there is a significant call for rigorous randomized controlled trials, aiming to directly compare various approaches, potentially meeting diverse patient preferences and requirements. Along with this, there’s a need for more systematic investigations into how psychological interventions impact not just psychological but also biological markers of stress. This study directly tackles both of these questions.

To ascertain the relative effectiveness of three eight-week eHealth support programs for cancer patients’ mental health, a rigorous randomized controlled clinical trial will be executed. All programs will be imparted via the MOU MindCare mobile device application.

At the conclusion of their adjuvant treatment regimen (chemotherapy, radiotherapy, or both), 440 breast cancer survivors will be randomly divided into one of four groups: Mindfulness-Based Cognitive Therapy for Cancer (MBCT-Ca), Positive Psychology (PP), Autogenic Training (AT), or the standard treatment approach (TAU). The study will include assessments of psychological and biological stress indicators and adaptive functioning at four designated points: baseline (T0), after treatment (T1), three months later (T2), and nine months later (T3).